To date, there is conflicting evidence regarding the effect of MnTBAP on adiposity and in vivo insulin action [8,15], and it remains unknown whether MnTBAP can ameliorate pre-existing obesity and insulin resistance by altering energy homeostasis. This evidence concerns the gene INS and obesity disorder.